TY - JOUR
T1 - Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO system
AU - Hayashida, Tetsu
AU - Nagayama, Aiko
AU - Seki, Tomoko
AU - Takahashi, Maiko
AU - Matsumoto, Akiko
AU - Kubota, Anna
AU - Jinno, Hiromitsu
AU - Miyata, Hiroaki
AU - Kitagawa, Yuko
N1 - Funding Information:
SHIONOGI Inc.; Cabinet Office of Japan, Cross‐ministerial Strategic Innovation Promotion Program, “Innovative AI Hospital System”; JSPS KAKENHI, Grant‐in‐Aid for Scientific Research (C), Grant/Award Number: 19K09082.
Funding Information:
T. Hayashida and H. Miyata received research funding from SHIONOGI Inc. T. Hayashida and Y. Kitagawa are editorial board members of . There are no other disclosures to be made for this research. Cancer Science
Funding Information:
SHIONOGI Inc.; Cabinet Office of Japan, Cross-ministerial Strategic Innovation Promotion Program, “Innovative AI Hospital System”; JSPS KAKENHI, Grant-in-Aid for Scientific Research (C), Grant/Award Number: 19K09082. The LINE-ePRO system used in this study was established with research funding from SHIONOGI Inc. This study was carried out as part of Cabinet Office of Japan, the Cross-ministerial Strategic Innovation Promotion Program, “Innovative AI Hospital System” using the provided research funds. This work was also supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research (C), Grant Number 19K09082.
Publisher Copyright:
© 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
PY - 2022/5
Y1 - 2022/5
N2 - Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient-reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility study was undertaken on breast cancer patients by building a PRO data collection system based on LINE, one of the most popular social network service applications in Japan. In this study, one or more predefined PRO questions for each breast cancer patient's clinical situation were sent to the patient’s LINE application daily. The patient selected a predefined answer by tapping the screen, but no free-text answers were allowed. Seventy-three patients were enrolled. The median observation period was 435 days (84-656 days), and the total number of PROs collected was 16,417, with a mean of 224.9 reports per patient. Patients on adjuvant endocrine therapy were notified of 2.5 questions per week, and the median number of responses per week and response rate were 2.387 (1.687-11.627) and 95.5%, respectively. Analyzing the results by age group, the number of responses from those aged 60 and above was equal to or higher than that of the younger age group. It was also possible to track each patient’s PROs accurately. These results suggested that the design of the system, based on an application used daily, instead of using specifically prepared applications for collecting electronic PROs, was the reason for the favorable acceptance from patients and the satisfactory response rate from all age groups, including the elderly.
AB - Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient-reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility study was undertaken on breast cancer patients by building a PRO data collection system based on LINE, one of the most popular social network service applications in Japan. In this study, one or more predefined PRO questions for each breast cancer patient's clinical situation were sent to the patient’s LINE application daily. The patient selected a predefined answer by tapping the screen, but no free-text answers were allowed. Seventy-three patients were enrolled. The median observation period was 435 days (84-656 days), and the total number of PROs collected was 16,417, with a mean of 224.9 reports per patient. Patients on adjuvant endocrine therapy were notified of 2.5 questions per week, and the median number of responses per week and response rate were 2.387 (1.687-11.627) and 95.5%, respectively. Analyzing the results by age group, the number of responses from those aged 60 and above was equal to or higher than that of the younger age group. It was also possible to track each patient’s PROs accurately. These results suggested that the design of the system, based on an application used daily, instead of using specifically prepared applications for collecting electronic PROs, was the reason for the favorable acceptance from patients and the satisfactory response rate from all age groups, including the elderly.
KW - breast cancer
KW - electronic patient-reported outcome
KW - patient-reported outcome
UR - http://www.scopus.com/inward/record.url?scp=85127292529&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127292529&partnerID=8YFLogxK
U2 - 10.1111/cas.15329
DO - 10.1111/cas.15329
M3 - Article
C2 - 35279907
AN - SCOPUS:85127292529
SN - 1347-9032
VL - 113
SP - 1722
EP - 1730
JO - Cancer science
JF - Cancer science
IS - 5
ER -